1. Home
  2. BPTH vs ITP Comparison

BPTH vs ITP Comparison

Compare BPTH & ITP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • ITP
  • Stock Information
  • Founded
  • BPTH 2007
  • ITP 1996
  • Country
  • BPTH United States
  • ITP China
  • Employees
  • BPTH N/A
  • ITP N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • ITP Paper
  • Sector
  • BPTH Health Care
  • ITP Basic Materials
  • Exchange
  • BPTH Nasdaq
  • ITP Nasdaq
  • Market Cap
  • BPTH 2.2M
  • ITP 2.4M
  • IPO Year
  • BPTH N/A
  • ITP N/A
  • Fundamental
  • Price
  • BPTH $0.87
  • ITP $0.28
  • Analyst Decision
  • BPTH Strong Buy
  • ITP
  • Analyst Count
  • BPTH 2
  • ITP 0
  • Target Price
  • BPTH $30.00
  • ITP N/A
  • AVG Volume (30 Days)
  • BPTH 81.3K
  • ITP 153.9K
  • Earning Date
  • BPTH 11-13-2024
  • ITP 11-07-2024
  • Dividend Yield
  • BPTH N/A
  • ITP N/A
  • EPS Growth
  • BPTH N/A
  • ITP N/A
  • EPS
  • BPTH N/A
  • ITP N/A
  • Revenue
  • BPTH N/A
  • ITP $69,849,788.00
  • Revenue This Year
  • BPTH N/A
  • ITP N/A
  • Revenue Next Year
  • BPTH N/A
  • ITP N/A
  • P/E Ratio
  • BPTH N/A
  • ITP N/A
  • Revenue Growth
  • BPTH N/A
  • ITP N/A
  • 52 Week Low
  • BPTH $0.86
  • ITP $0.20
  • 52 Week High
  • BPTH $21.60
  • ITP $0.42
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 34.38
  • ITP 61.70
  • Support Level
  • BPTH $0.86
  • ITP $0.22
  • Resistance Level
  • BPTH $0.92
  • ITP $0.30
  • Average True Range (ATR)
  • BPTH 0.06
  • ITP 0.02
  • MACD
  • BPTH 0.01
  • ITP 0.00
  • Stochastic Oscillator
  • BPTH 5.79
  • ITP 68.75

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It involves in production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments Dongfang Paper and Tengsheng Paper, which produces offset printing paper, corrugating medium paper and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

Share on Social Networks: